Stopping GLP-1 drugs before endoscopy to prevent stomach delay
Part of Digestive system clinical trials.
This study looks at whether pausing GLP-1 agonist medications (like Ozempic or Trulicity) for two weeks before an upper endoscopy can reduce the chance of food staying in the stomach during the procedure. It may help people who take these diabetes medicines and need a routine endoscopy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a planned upper endoscopy (not an emergency one).
- You do not have cancer or a blockage in your upper digestive tract.
- You have not had any previous stomach surgery.
- Your medical records must include key details like your age, sex, weight, diabetes history, and any stomach symptoms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if stopping semaglutide (a diabetes/weight-loss drug) for one week before a sedated endoscopy helps reduce leftover food in the stomach and improves how well doctors can see the stomach lining. It may help patients who need a clear view during the procedure.
This study uses an ultrasound to look at how full your stomach is after taking GLP-1 medications for diabetes or weight loss. It will help doctors understand if current fasting guidelines are safe before surgery or a colonoscopy.
This study tests whether drinking only clear liquids before an upper endoscopy can reduce leftover stomach contents in people taking GLP-1 medications (like Ozempic or Mounjaro). It may help make the procedure safer.
This study looks at whether people taking weekly GLP-1 medications (like Ozempic or Wegovy) should follow standard fasting rules or a 24-hour clear liquid diet before a procedure. The goal is to find the safest way to prepare.
This study looks at whether stopping GLP-1 receptor agonists (a type of diabetes or weight-loss medication) before a colonoscopy can help improve the procedure. It compares how well the bowel is cleaned in people who stop these drugs for a certain time versus those who continue them.
This trial is testing whether stopping GLP-1 receptor agonists or tirzepatide one week before an upper endoscopy (a scope that looks at your stomach and esophagus) is safe and effective. It's designed for people who are already taking these medications and have an upcoming procedure.
Hear when a new Gastric Retention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.